You have accessJournal of UrologyCME1 May 2022PD49-11 THREE YEARS AFTER FINISHING PENILE REHABILITATION STUDY PROGRAMS AND 5 YEARS AFTER NERVE-SPARING RADICAL PROSTATECTOMY: WHAT`S UP WITH OUR PATIENTS? Andreas Bannowsky, Daniar Osmonov, Viktoria Märker, and Stefan Ückert Andreas BannowskyAndreas Bannowsky More articles by this author , Daniar OsmonovDaniar Osmonov More articles by this author , Viktoria MärkerViktoria Märker More articles by this author , and Stefan ÜckertStefan Ückert More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002620.11AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Several strategies are published for postoperative erectile function rehabilitation after nerve-sparing radical prostatectomy (nsRP). The aim of our study was to evaluate the use of any ED-treatment or the adherence to study protocol medication 3 years after the end of the initiated rehabilitation program. METHODS: 124 patients (mean age 69 years) from 3 different rehabilitation studies after nsRP with a regular dose of different PDE5-inhibitors (sildenafil/vardenafil/tadalafil) were enrolled for this evaluation. The regular initial follow-up of all of the 3 studies was 24 months. We performed a questionnaire sent to all enrolled patients of these studies 3 years after the end of the study / 5 years after nsRP. The survey consists of different questions, e.g. if and what kind of ED-treatment the patients still use. Further questions dealt with the reasons to end the study medication or switch to any other treatment. RESULTS: 99 patients (79.8%) completed and returned the questionnaire. 51 patients (52%) had stopped medical ED-treatment therapy completely at the time of the survey because of different reasons (completely restored erectile function without any medication 11%, subsequent ineffectiveness of the medication 8%, progressive disease of prostate cancer 7%, subsequent comorbidities 25%). From the remaining 48 patients only 21 patients (21%) still using only PDE5-inhibitors (daily or on demand). 16 patients (16%) using penile injection therapy, 3 patients MUSE (3%) and 8 patients VCD (with/without PDE5-inhibitors) (8%). CONCLUSIONS: 5 years after nsRP / 3 years after the end of the different rehabilitation studies most of the patients (52%) don´t use any ED-medication anymore due to different reasons. Only 11% of the patients after being enrolled in rehabilitation programs for 24 months are still reporting a restored erectile function 5 years after nsRP without any medication. Source of Funding: None © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e834 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Andreas Bannowsky More articles by this author Daniar Osmonov More articles by this author Viktoria Märker More articles by this author Stefan Ückert More articles by this author Expand All Advertisement PDF DownloadLoading ...